GoodRx Holdings (GDRX) Operating Expenses (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of Operating Expenses data on file, last reported at $180.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses changed 0.23% year-over-year to $180.0 million; the trailing twelve-month figure through Mar 2026 stood at $709.8 million (down 0.81% YoY), and the FY2025 full-year result was $709.4 million, down 2.36% from the prior year.
• Operating Expenses advanced to $180.0 million in Q1 2026, from $172.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $218.3 million in Q3 2023 to a low of $171.4 million in Q2 2023.
• A 5-year average of $185.8 million and a median of $180.7 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses climbed 17.85% in 2023 and dropped 19.9% in 2024, its largest moves.
• Tracing GDRX's Operating Expenses over 5 years: stood at $182.4 million in 2022, then rose by 17.85% to $214.9 million in 2023, then retreated by 16.07% to $180.4 million in 2024, then slipped by 4.6% to $172.1 million in 2025, then climbed by 4.59% to $180.0 million in 2026.
• Business Quant data shows GDRX's Operating Expenses at $180.0 million in Q1 2026, $172.1 million in Q4 2025, and $181.4 million in Q3 2025.